Supplement and Nutraceutical Business Loans: Funding a High-Risk Category

By MercFinancial · Published 2026-10-22 · Updated 2026-10-21

Supplement and nutraceutical brands are flagged for claims, continuity chargebacks and FDA and FTC exposure, yet they are SBA-eligible and financed on receivables, inventory and sales. The compliance evidence that opens the file.

Supplement and nutraceutical business loans exist, and they come from funding sources that have made peace with the category's reputation: receivables factors that advance against retailer and distributor invoices, purchase order and inventory lenders that pay the contract manufacturer, revenue-based funders that underwrite the sales, high-risk merchant lenders built for continuity offers, and SBA 7(a) lenders for an established brand. Dietary supplements are not excluded from SBA lending and do not appear by name on the restricted lists several large online lenders publish, but many payment processors classify nutraceuticals as high-risk, and that label follows the file. The reasons are claims, trials, chargebacks and two federal regulators. An e-commerce supplement brand carries every flag an online retailer carries, plus those.

This guide covers why processors and lenders flag nutraceuticals, the financing that works for manufacturing and inventory, receivables from retailers as the category's cleanest asset, the compliance evidence lenders want in the file, an illustrative retailer order funded end to end, the mistakes that get supplement files declined, and where MercFinancial fits.

The lender is not asking whether the supplement works. It is asking whether the claims, the trial offer and the chargebacks survive a year.

Why processors and lenders flag nutraceuticals

Three things make a supplement brand a flagged file, and they compound. The first is claims. Under the Dietary Supplement Health and Education Act, a supplement is sold without premarket approval, and a brand may make structure and function claims with the required disclaimer and a notification to the FDA. A claim that a product treats, cures or prevents a disease makes it an unapproved drug, and the FTC separately requires that advertising claims be substantiated. Warning letters and class actions in this category are common enough that a lender assumes exposure until the file shows otherwise.

The second is the offer. Free trials, continuity shipments and negative-option billing drove the category's online growth and its chargeback problem. Card networks run chargeback monitoring programs with low thresholds, and major payment processors list continuity models among the businesses they restrict or price as high-risk. A trial offer with a dispute ratio near the threshold is the profile processors terminate, and a lender advancing against card receipts knows it.

The third is manufacturing. Most brands outsource production, and the FDA's current good manufacturing practice rules for dietary supplements, 21 CFR Part 111, apply to the finished product whoever makes it. A contract manufacturer with a poor inspection history is the brand's problem and therefore the lender's. The guide to why lenders flag e-commerce and subscription businesses covers the flags every online brand carries on top of these.

Financing the manufacturing run and the inventory

A supplement brand's cash cycle starts with a deposit to the contract manufacturer, continues through raw material lead times, production, testing and release, and ends weeks or months later when the product sells through. Purchase order financing pays the manufacturer for finished goods against a confirmed order from a retailer or distributor, and PO funders will write nutraceuticals when the manufacturer is cGMP-compliant, the product is finished and tested, and the buyer is creditworthy. They will not fund a direct-to-consumer forecast or a product still in formulation.

Inventory lines advance against the landed cost of finished, released inventory in the brand's warehouse or 3PL, with shelf life and lot-level traceability added to the usual aging and exclusion rules. Raw materials, work in process and short-dated stock are typically excluded. Revenue-based advances fund the run from future sales when no order exists, at the highest cost of the three and with the claims and trial offer reviewed before approval. A brand that manufactures in-house finances encapsulation, blending and packaging lines through equipment lenders, like any production equipment with a resale market. The guide to inventory financing for e-commerce covers the turn math that applies here too.

Receivables from retailers: the cleanest asset in the category

The one asset in a supplement brand that most lenders like is an invoice to a retailer or a distributor. A national grocery, drug or specialty chain, or a distributor serving independent stores, is a creditworthy debtor on standard terms, and a factor advances against that invoice at shipment, commonly roughly 70 to 90 percent of its face with fees quoted per 30 days, and collects from the retailer. The factor is underwriting the retailer's credit, not the brand's, which is why factoring is open to brands that nothing else is.

Factoring has conditions of its own. Retailer chargebacks for promotions, slotting, returns and shortages reduce what the factor collects, so the advance is set with reserves for them. The brand's product liability insurance and the retailer's indemnity requirements are checked. And the factor wants a clean, direct relationship: no prior lien on receivables from a revenue-based funder, and no retailer that disputes invoices as a matter of course. For a brand moving from direct-to-consumer into retail, a factoring line is often the first institutional capital it qualifies for. The invoice factoring versus PO financing guide shows how the two combine on one order.

The compliance evidence lenders want in the file

The general package in the business loan documents checklist still applies. In supplements, the compliance file is what turns a flagged category into a fundable brand.

Illustrative example: a retailer order funded end to end

Illustrative example, hypothetical and rounded: a brand receives a $200,000 purchase order from a regional grocery chain for a product its contract manufacturer will produce for $80,000. A PO funder pays the manufacturer, the goods ship with certificates of analysis, and the invoice goes to a factor that advances 80 percent of its face, $160,000, at shipment. The factor repays the PO funder from that advance and sends the brand the difference less fees, then collects from the chain on its terms and releases the reserve, less any promotional chargebacks, when it pays. A retail launch has been funded with no bank loan and no equity.

The numbers are illustrative and the funding source sets the real ones. What matters is the structure: with a confirmed order, a compliant product and a creditworthy buyer, a supplement brand can be financed on its customer's credit rather than its own. What breaks the chain is a claims problem that makes the retailer cancel, a manufacturer that misses release, or a prior lien from a revenue-based advance that blocks the factor.

Mistakes that get supplement files declined

• Disease claims anywhere. A single page that says a product treats or prevents a condition stops most lenders at the website review.
• Trial offers with no dispute data. A continuity model without a processor statement showing the chargeback ratio is assumed to be over the threshold.
• No certificates of analysis. Product without lot-level testing cannot be valued as inventory or shipped to most retailers.
• A prior lien on receivables. A revenue-based advance filed against all assets blocks the factor that would have been cheaper.
• Raw material as collateral. Inventory lenders fund finished, released, in-date product, not powder in drums.

Where MercFinancial fits

MercFinancial is a commercial funding broker in Houston, not a lender. A supplement or nutraceutical request starts with the compliance file and the processing history, because those decide which funding sources will read the rest. From more than 160 funding sources, the factors, PO and inventory lenders, revenue-based funders, high-risk merchant lenders and SBA lenders whose policy allows nutraceuticals and the structure in question are identified, one file goes to all of them, and the offers are compared on total cost. Whether a brand qualifies, and on what terms, depends on the funding source, and a brand with a claims problem or a dispute ratio in a monitoring program hears that first, with what to fix. Stephanie, the AI lending assistant, pre-qualifies a request in a few minutes with a soft credit pull, and a free 30-minute call with a funding specialist follows. See e-commerce business funding for the industry hub or business funding for every program.

Frequently Asked Questions

Why are supplement companies considered high-risk?

Because of health claims that can draw FDA and FTC enforcement, free-trial and continuity offers that produce chargebacks, and manufacturing that must meet the FDA's cGMP rules whoever makes the product. Many payment processors classify nutraceuticals as high-risk for those reasons, and lenders advancing against card receipts read the processing history before anything else. The category is not excluded from SBA or most lending.

Can a supplement business get an SBA loan?

Yes. Dietary supplement brands are not excluded under 13 CFR 120.110, and an established brand with tax returns, margins and a compliant product can use a 7(a) loan for inventory, working capital or equipment, subject to the individual lender's credit policy. Lenders look closely at claims, the manufacturer's compliance and the processing history, and many prefer brands with retail or distributor sales.

What financing works for a new supplement brand?

Purchase order financing for a confirmed retailer or distributor order, factoring on the resulting invoices, and a revenue-based advance against existing sales. A brand with only a forecast and a direct-to-consumer launch is usually limited to the advance and the owner's personal credit until it has sales history, certificates of analysis and a clean processing record.

Can I factor invoices to retailers for a supplement product?

Yes, and it is often the first institutional capital a supplement brand qualifies for. A factor advances against invoices to creditworthy retailers and distributors at shipment, commonly roughly 70 to 90 percent of face, and collects from the retailer. Reserves are held for promotional chargebacks and returns, product liability insurance is checked, and no prior lien on receivables can be in place.

What compliance documents do lenders want from a supplement company?

A label and claims review against DSHEA and FTC standards, the contract manufacturer's cGMP status and quality agreement, lot-level certificates of analysis from an accredited lab, product liability insurance, a written adverse event reporting procedure, and twelve months of processor statements showing the chargeback ratio. Together they turn a flagged category into a fundable brand.

MercFinancial is a commercial funding brokerage in Houston, Texas. MercFinancial is a broker, not a lender: every loan is made by a third-party funding source, every request is subject to that source's underwriting and credit approval, and loan amounts, advance rates, interest rates, terms, fees, collateral and guaranty requirements vary by funding source and borrower and are not guaranteed. Nothing here is a commitment to lend or an offer of credit, and financing is for business purposes only. Any example in this guide is hypothetical and illustrative; actual terms and outcomes vary. Dietary supplements are regulated by the FDA and the FTC; card-not-present businesses are subject to card-network chargeback programs; financing availability depends on the funding source's policies. This guide is educational only and is not legal, tax, accounting or investment advice.